Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal testosterone for genitourinary syndrome of menopause in women with breast cancer on aromatase inhibitors
ACTRN12615000083594Phase 2Completed
- Sponsor
- Monash University
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vaginal atrophy and female sexual dysfunction (FSD) comparing Intravaginal testosterone cream with Placebo cream (2 arms). Primary endpoint: Female Sexual Function Index satisfaction domain score. Started Dec 2016; status: completed.
02
Drugs
testosterone
03
Conditions
vaginal atrophyfemale sexual dysfunction (FSD)
Beyond the preview
Go deeper on ACTRN12615000083594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000083594.